Skip to main content
Have a personal or library account? Click to login
Syringin inhibits insulin resistance through the PI3K/AKT pathway Cover

Syringin inhibits insulin resistance through the PI3K/AKT pathway

Open Access
|Oct 2026

References

  1. P. Gupta, P. Singh, R. Garg, G. R. Valicherla, M. Riyazuddin, A. A. Syed, Z. Hossain and J. R. Gayen, Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice, Biomed. Pharmacother. 116 (2019) Article ID 108959 (12 pages); https://doi.org/10.1016/j.biopha.2019.108959
  2. A. Nakashima, K. Kato, I. Ohkido and T. Yokoo, Role and treatment of insulin resistance in patients with chronic kidney disease: A review, Nutrients 13(12) (2021) Article ID 4349 (11 pages); https://doi.org/10.3390/nu13124349
  3. D. Camer, Y. Yu, A. Szabo, C. H. Dinh, H. Wang, L. Cheng and X. F. Huang, Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high fat diet, Mol. Cell. Endocrinol. 412 (2015) 36–43; https://doi.org/10.1016/j.mce.2015.05.018
  4. D. S. Kim, S. K. Jeong, H. R. Kim, D. S. Kim, S. W. Chae and H. J. Chae, Metformin regulates palmi-tate induced apoptosis and ER stress response in HepG2 liver cells, Immunopharmacol. Immunotoxicol. 32(2) (2010) 251–257; https://doi.org/10.3109/08923970903252220
  5. H. E. Lebovitz, Insulin resistance: Definition and consequences, Exp. Clin. Endocrinol. Diab. 109(Suppl 2) (2001) 135–148; https://doi.org/10.1055/s2001-18576
  6. J. J. Senn, P. J. Klover, I. A. Nowak and R. A. Mooney, Interleukin 6 induces cellular insulin resistance in hepatocytes, Diabetes 51(12) (2002) 3391–3399; https://doi.org/10.2337/diabetes.51.12.3391
  7. J. Yu, Q. Chu, J. Zhou and L. Zhang, The novel fish miRNA, Soc-miR118, functions as a negative regulator in NFκB mediated inflammation by targeting IL6 in teleost fish, Int. J. Biol. Macromol. 269(1) (2024) Article ID 132100; https://doi.org/10.1016/j.ijbiomac.2024.132100
  8. M. S. H. Akash, K. Rehman and A. Liaqat, Tumor necrosis factor alpha: Role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus, J. Cell Biochem. 119(1) (2018) 105–110; https://doi.org/10.1002/jcb.26174
  9. N. Akhter, A. Wilson, H. Arefanian, R. Thomas, S. Kochumon, F. AlRashed, M. AbuFarha, A. Al-Madhoun, F. AlMulla, R. Ahmad and S. Sindhu, Endoplasmic reticulum stress promotes the expression of TNF-a in THP1 cells by mechanisms involving ROS/CHOP/HIF1α and MAPK/NFκB pathways, Int. J. Mol. Sci. 24(20) (2023) Article ID 15186 (26 pages); https://doi.org/10.3390/ijms242015186
  10. N. H. Kim, J. Jegal, Y. N. Kim, J. D. Heo, J. R. Rho, M. H. Yang and E. J. Jeong, Chokeberry extract and its active polyphenols suppress adipogenesis in 3T3-L1 adipocytes and modulates fat accumulation and insulin resistance in dietinduced obese mice, Nutrients 10(11) (2018) Article ID 1734 (14 pages); https://doi.org/10.3390/nu10111734
  11. N. Kubota, T. Kubota and T. Kadowaki, Physiological and pathophysiological actions of insulin in the liver, Endocr. J. 72(2) (2025) 149–159; https://doi.org/10.1507/endocrj.EJ24-0192
  12. Q. Qian, J. Pan, J. Yang, R. Wang, K. Luo, Z. Wu, S. Ma, Y. Wang, M. Li and Y. Gao, Syringin: A naturally occurring compound with medicinal properties, Front. Pharmacol. 15 (2024) Article ID 1435524 (18 pages); https://doi.org/10.3389/fphar.2024.1435524
  13. S. A. Malik, J. D. Acharya, N. K. Mehendale, S. S. Kamat and S. S. Ghaskadbi, Pterostilbene reverses palmitic acid mediated insulin resistance in HepG2 cells by reducing oxidative stress and triglyceride accumulation, Free Radic. Res. 53(7) (2019) Article ID 815827; https://doi.org/10.1080/10715762.2019.1635252
  14. S. Mohan, A. Nair, M. S. Poornima and K. G. Raghu, Vanillic acid mitigates hyperinsulinemia induced ER stress mediated altered calcium homeostasis, MAMs distortion and surplus lipogenesis in HepG2 cells, Chem. Biol. Interact. 375 (2023) Article ID 110365; https://doi.org/10.1016/j.cbi.2023.110365
  15. T. V. Rohm, D. T. Meier, J. M. Olefsky and M. Y. Donath, Inflammation in obesity, diabetes, and related disorders, Immunity 55(1) (2022) 31–55; https://doi.org/10.1016/j.immuni.2021.12.013
  16. V. L. Tokarz, P. E. MacDonald and A. Klip, The cell biology of systemic insulin function, J. Cell Biol. 217(7) (2018) 2273–2289; https://doi.org/10.1083/jcb.201802095
  17. X. Huang, G. Liu, J. Guo and Z. Su, The PI3K/AKT pathway in obesity and type 2 diabetes, Int. J. Biol. Sci. 14(11) (2018) 1483–1496; https://doi.org/10.7150/ijbs.27173
  18. X. Yao, L. Liu, W. Shao, M. Bai, X. Ding, G. Wang, S. Wang, L. Zheng, Y. Sun, G. Wang, Y. Huang, C. Yu, Z. Song, Y. Bao, S. Yang and L. Sun, Tectorigenin targets PKACα to promote GLUT4 expression in skeletal muscle and improve insulin resistance in vitro and in vivo, Int. J. Biol. Sci. 19(5) (2023) 1579–1596; https://doi.org/10.7150/ijbs.80125
  19. X. Zhou, L. L. Wang, W. J. Tang and B. Tang, Astragaloside IV inhibits protein tyrosine phosphatase 1B and improves insulin resistance in insulin resistant HepG2 cells and triglyceride accumulation in oleic acid (OA)treated HepG2 cells, J. Ethnopharmacol. 268 (2021) Article ID 113556; https://doi.org/10.1016/j.jep.2020.113556
  20. Y. Li, X. Chen, Y. Chen, D. Yu, R. Jiang, X. Kou, L. Sheng, Y. Liu and Y. Song, Berberine improves TNF-a induced hepatic insulin resistance by targeting Mekk1/Mek Pathway, Inflammation 45(5) (2022) 2016–2026; https://doi.org/10.1007/s10753-022-01671-8
  21. Y. Y. Qiu, J. Zhang, F. Y. Zeng and Y. Z. Zhu, Roles of the peroxisome proliferatoractivated receptors (PPARS) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD), Pharmacol. Res. 192 (2023) Article ID 106786 (16 pages); https://doi.org/10.1016/j.phrs.2023.106786
  22. Z. Cheng, Y. Tseng and M. F. White, Insulin signaling meets mitochondria in metabolism, Trends Endocrinol. Metab. 21(10) (2010) 589–598; https://doi.org/10.1016/j.tem.2010.06.005
DOI: https://doi.org/10.2478/acph-2026-0024 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Accepted on: Sep 1, 2026
Published on: Oct 13, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2026 Haitao Wang, Jianjian Han, Lu Yun, Xiaolei Wang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.